Injection of fibrin sealant including an anesthetic in spinal applications
A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus. The method includes injecting a fibrin sealant into the disc to reduce at least a portion of the at least one defect, wherein the fibrin sealant injected into the disc comprises an anesthetic, fibrinogen and an activating compound, wherein at least a portion of the fibrin forms after injection, with the proviso that a corticosteroid is absent from the fibrin sealant injected into the disc.
1. A kit, comprising: an anesthetic, fibrinogen, thrombin, a spinal needle, and an introducer needle, wherein spinal needle is of a length that does not extend past the tip of an introducer needle during use, wherein the kit excludes corticosteroid and wherein the kit excludes a device to provide thermal energy to a disc.
2. The kit of claim 1 , wherein the anesthetic is a local anesthetic and wherein the local anesthetic is lidocaine, sarapin or bupivicaine.
3. The kit of claim 1 , further comprising calcium chloride.
4. The kit of claim 1 , further comprising an additive, wherein the additive is selected from the group consisting of antibiotics; antiproliferative, cytotoxic, and antitumor drugs; analgesic; antiangiogen; antivirals; cytokines; colony stimulating factors; proteins; chemoattractants; EDTA; histamine; antihistamine; erythropoietin; antifungals; antiparasitic agents; non-corticosteroid anti-inflammatory agents; anticoagulants; oncology agents; cardiovascular drugs; glycoproteins; fibronectin; peptides interferons; cartilage inducing factors; protease inhibitors; vasoconstrictors, vasodilators, demineralized bone or bone morphogenetic proteins; hormones; lipids; carbohydrates; proteoglycans; antiangiogenins; antigens; DBM; hyaluronic acid and salts and derivatives thereof; polysaccharides; cellulose compounds and derivatives thereof; antibodies; gene therapy reagents; genetically altered cells, stem cells and/or other cells; cell growth factors; type II collagen; collagen hydrolyzate; elastin; sulfated glycosaminoglycan (sGAG), glucosamine sulfate; pH modifiers; methylsulfonylmethane (MSM); osteogenic compounds; osteoconductive compounds; plasminogen; nucleotides; oligonucleotides; polynucleotides; polymers; osteogenic protein 1 (OP-1); LMP-1 (Lim Mineralization Protein-1); cartilage; oxygen-containing components; enzymes; melatonin; vitamins; and nutrients.
5. The kit of claim 1 , wherein the fibrinogen and thrombin are in a freeze-dried state.
6. The kit of claim 1 , further comprising a dual barrel syringe.
7. The kit of claim 1 , further comprising an additive.
8. The kit of claim 1 , wherein the fibrinogen is in a frozen state and the thrombin is in a frozen state.